JOSE MONDEJAR: Open Payments
NPI 1447029509 · JERSEY CITY, NJ. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,682 in 75 payments from 19 companies in 2025. Trend: 2023 $0 · 2024 $1,002 · 2025 $1,682
Food & beverage: $1,682
| Company | Payments | Amount |
|---|---|---|
| Amgen Inc. | 14 | $449 |
| Novo Nordisk Inc | 13 | $223 |
| GlaxoSmithKline, LLC. | 6 | $210 |
| Ardelyx, Inc. | 8 | $168 |
| Lilly USA, LLC | 8 | $163 |
| Phathom Pharmaceuticals, Inc. | 5 | $61 |
| Exact Sciences Corporation | 2 | $58 |
| Bayer Healthcare Pharmaceuticals Inc. | 3 | $54 |
| PFIZER INC. | 3 | $52 |
| Otsuka America Pharmaceutical, Inc. | 2 | $42 |
Products named: OTEZLA, SHINGRIX, IBSRELA, REPATHA, MOUNJARO, Ozempic, Rybelsus, VOQUEZNA.
Industry payments across NJ — which companies pay providers there.
